Review
Open access
Aug 2026
Microbiome–Immune Interactions as Determinants of Checkpoint Inhibitor Efficacy in Hepatocellular Carcinoma
Collectively, microbiome-based approaches may contribute to the development of personalized immunotherapeutic strategies in HCC, although larger standardized prospective studies are required before microbiome-derived biomarkers can be implemented in routine clinical practice.
Mădălina-Raluca Ostafe, S. Volovat, Ana Clement et al.
· International Journal of Mol... · 0 citations